Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

81.16
Delayed Data
As of Sep 23
 -0.13 / -0.16%
Today’s Change
67.88
Today|||52-Week Range
88.48
-3.68%
Year-to-Date
Takeover Chatter Around Clovis May Be Overdone
Sep 23 / TheStreet.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
Could This Alzheimers Disease Drug Really Be Worth $20 Billion?
Sep 19 / MotleyFool.com - Paid Partner Content
New Setback for Sanofi's Lantus Increases Need for M&A
Sep 22 / TheStreet.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Eli Lilly Can't Put the Petal to the Metal
Sep 21 / TheStreet.com - Paid Partner Content
Sanofi Fighting a Losing Battle Sues Merck for Alleged Patent Infrigement
Sep 19 / TheStreet.com - Paid Partner Content
An Options Play in Eli Lilly
Sep 20 / TheStreet.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close81.29
Today’s open80.97
Day’s range80.77 - 81.46
Volume2,197,653
Average volume (3 months)3,822,153
Market cap$89.6B
Dividend yield2.51%
Data as of 4:01pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.60%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.75%
P/E ratio35.0
Price/Sales4.50
Price/Book6.16

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.69-1.51%
AZNAstraZeneca-0.31-0.90%
CELGCelgene-1.14-1.03%
BMYBristol-Myers Squibb+0.06+0.11%
Data as of 4:03pm ET, 09/23/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.96
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Search for Jobs